title: Transcription factor Fra-1 induces cholangitis and liver fibrosis.
abstract: Chronic diseases of the biliary system are common and may cause fibrosis and eventually progression to liver cirrhosis. The aim was to define a new mouse model of a cholangiopathy leading to liver fibrosis in fra-1tg mice. Liver pathology of fra-1tg mice was analyzed in detail by histology and flow cytometry. Transcript levels of fibrosis-related genes and matrix metalloproteinase (MMP) activities were quantified and immunohistochemical analysis additionally applied. The role of the immune system in this model was analyzed by crossing fra-1tg mice with rag2(-/-) mice. Furthermore, expression of Fra-1 in corresponding human liver diseases was investigated on transcription level and histologically. Fra-1tg mice spontaneously develop biliary fibrosis preceded by ductular proliferation and infiltration of inflammatory cells. Fra-1 protein is present in cholangiocytes and inflammatory cells within the liver. These findings were replicated in human biopsies of patients with advanced liver fibrosis. The inflammatory infiltrate showed a strong increase in activated T cells and decreased natural killer (NK), natural killer T cells (NKT), and B cells in fra-1tg mice as compared to wildtype mice. Moreover, fra-1tg mice develop biliary fibrosis with a time-dependent increase in hepatic collagen content and increase in relative messenger RNA (mRNA) expression of profibrotic genes. Attenuation but not complete prevention of collagen accumulation in liver was observed in the fra-1tg × rag2(-/-) mice. However, transplantation of fra-1tg bone marrow cells into wildtype mice could not induce disease.
  
  
  CONCLUSIONS
  Fra-1tg mice spontaneously develop a progressive biliary disease. These mice are an attractive model for the investigation of cholangiopathies and their interaction with the immune system.
authors.affiliation: Department of Internal Medicine 3, University of Erlangen-Nuremberg, Germany.
authors.forename: Trayana
authors.initials: T
authors.lastname: Kireva
authors.forename: Annette
authors.initials: A
authors.lastname: Erhardt
authors.forename: Gisa
authors.initials: G
authors.lastname: Tiegs
authors.forename: Herbert
authors.initials: H
authors.lastname: Tilg
authors.forename: Helmut
authors.initials: H
authors.lastname: Denk
authors.forename: Johannes
authors.initials: J
authors.lastname: Haybaeck
authors.forename: Elmar
authors.initials: E
authors.lastname: Aigner
authors.forename: Alexander
authors.initials: A
authors.lastname: Moschen
authors.forename: Jörg H
authors.initials: JH
authors.lastname: Distler
authors.forename: Georg
authors.initials: G
authors.lastname: Schett
authors.forename: Jochen
authors.initials: J
authors.lastname: Zwerina
mesh_terms: D000818:Animals; D018925:Chemokines / Q000096:biosynthesis; D002761:Cholangitis / Q000139:chemically induced*; D004195:Disease Models, Animal; D005355:Fibrosis; D006801:Humans; D008099:Liver / Q000378:metabolism; D008103:Liver Cirrhosis / Q000139:chemically induced* / Q000473:pathology; D051379:Mice; D008822:Mice, Transgenic; D016760:Proto-Oncogene Proteins c-fos / Q000502:physiology*; D018808:Transcription Factor AP-1 / Q000502:physiology; D000099169:Fos-Related Antigen 1
chemical_list: D018925:Chemokines; D016760:Proto-Oncogene Proteins c-fos; D018808:Transcription Factor AP-1; D000099169:Fos-Related Antigen 1